-
Medigene AG (FSE: MDG1, ISIN DE000A1X3W00,
Prime Standard) is a
publicly listed biotechnology company headquartered in
Martinsried near Munich, Germany...
-
hosts many biotech-companies, like ADVA
Optical Networking, GPC Biotech,
MediGene and MorphoSys. In addition, the Max
Planck Institute of
Biochemistry and...
- T-cell
receptor technology.
Immunocore was
founded in 2008 as a
spinout of
MediGene AG,
which acquired Avidex in 2006. The core
technology was spun out of...
-
verazide (INN)
Vercyte (Abbott)
Verdeso (Connetics Corporation)
Veregen (
MediGene)
Verelan Pm
Verelan Vergon Veriloid verilopam (INN)
Verkazia verlukast...
-
brain tumours. NV1020 is an
oncolytic herpes virus initially developed by
Medigene Inc. and
licensed for
development by
Catherex Inc. in 2010. NV1020 has...
- and from 1998 to 1999 as vice
president of
research and development,
MediGene AG, Martinsried, Germany.
Gissmann was a
member of the DKFZ
board of trustees...
-
GroupPharma GmbH Janssen-Cilag GmbH
Lilly Pharma Holding GmbH
Lundbeck GmbH
MediGene AG
Merck KGaA
Merck & Co
named MSD
Sharp &
Dohme on vfa
website Mundipharma...
- in
animals and humans. By 1999, the
inventor had
granted a
license to
MediGene AG (Martinsried, Germany) for
further development as a drug
against congestive...
